|
UBE2E3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.55190000000039E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.020600E-04 |
| Normal-vs-Stage2 |
6.278500E-03 |
| Normal-vs-Stage3 |
2.020100E-04 |
| Normal-vs-Stage4 |
2.71590000044952E-07 |
| Stage1-vs-Stage2 |
7.635000E-01 |
| Stage1-vs-Stage3 |
4.613800E-01 |
| Stage1-vs-Stage4 |
1.950260E-02 |
| Stage2-vs-Stage3 |
8.442400E-01 |
| Stage2-vs-Stage4 |
2.371400E-01 |
| Stage3-vs-Stage4 |
1.642580E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.56679999999887E-05 |
| Normal-vs-AfricanAmerican |
7.579600E-02 |
| Normal-vs-Asian |
2.518500E-03 |
| Caucasian-vs-AfricanAmerican |
2.858000E-01 |
| Caucasian-vs-Asian |
5.931000E-01 |
| AfricanAmerican-vs-Asian |
5.332800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.12619999999664E-05 |
| Normal-vs-Female |
1.755370E-04 |
| Male-vs-Female |
1.667790E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.41060000000437E-05 |
| Normal-vs-Age(41-60Yrs) |
2.240000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.37479999999346E-05 |
| Normal-vs-Age(81-100Yrs) |
7.150400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.067400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.404600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.097600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.510380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.718000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.121000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.779600E-02 |
| Classical-VS-Follicular |
5.907000E-01 |
| Classical-VS-Other |
6.144600E-01 |
| Classical-VS-Normal |
1.237540E-04 |
| Tall-VS-Follicular |
3.734600E-01 |
| Tall-VS-Other |
7.653000E-01 |
| Tall-VS-Normal |
1.624630E-04 |
| Follicular-VS-Other |
8.688800E-01 |
| Follicular-VS-Normal |
1.640700E-03 |
| Other-VS-Normal |
5.032200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.11000000000161E-05 |
| Normal-vs-N1 |
2.3084000044804E-08 |
| N0-vs-N1 |
9.236900E-03 |
|
|
